Floatz logo

Epacadostat

Lymphoma

University of California, DavisSmall moleculePhase 1/2Dormant
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
65/ 100

Competitive context

289 Active assets in the Lymphoma cohort.

View all 50

Same molecule, other indications

Epacadostat is also rated in:

urothelial carcinomaDormant
BB
Indicative ·
65 / 100
View asset →
ovarian carcinomaDormant
B
Indicative ·
59 / 100
View asset →
renal cell carcinomaDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →